"UCF Researchers in the Division of Cancer Research are on the vanguard of cancer biology."

During the past decade, Florida Cancer Specialists North Region Sarah Cannon Research conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Cancer Specialists North Region Sarah Cannon Research" #1 collaborator was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Florida Cancer Specialists North Region Sarah Cannon Research" are "Multiple Myeloma" (2 trials), "Advanced Solid Tumor" (1 trials), "Locally Advanced/Metastatic Solid Tumors" (1 trials), "Lymphoma, Non-Hodgkin" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Florida Cancer Specialists North Region Sarah Cannon Research" in a lesser frequency.

Most popular intervention types in "Florida Cancer Specialists North Region Sarah Cannon Research" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Daratumumab" (2 trials), "Dexamethasone" (2 trials), "Bortezomib" (1 trials), "Epoetin alfa" (1 trials) and "HY-0102" (1 trials). Other intervention names were less common.

The vast majority of trials in "Florida Cancer Specialists North Region Sarah Cannon Research" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Florida Cancer Specialists North Region Sarah Cannon Research". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Florida Cancer Specialists North Region Sarah Cannon Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Florida Cancer Specialists North Region Sarah Cannon Research, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".